TuHURA BIOSCIENCES, INC./NV Public Float
TuHURA BIOSCIENCES, INC./NV (HURA) had Public Float of $111.00 million as of 2025-06-30, per its 10-K/A filed 2026-04-30.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-04-30
- 2025-06-30: Entity Public Float $111.00M.
- 2024-06-30: Entity Public Float $14.93M.
- 2023-12-31: Entity Public Float $1.72B.
- 2022-12-31: Entity Public Float $11.50K.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $111.00M 10-K/A · filed 2026-04-30 |
| 2024-06-30 | $14.93M 10-K · filed 2025-03-31 |
| 2023-12-31 | $1.72B 10-K · filed 2024-10-07 |
| 2022-12-31 | $11.50K 10-K · filed 2023-09-18 |
| 2021-12-31 | $24.70M 10-K · filed 2022-09-27 |
| 2020-12-31 | $26.90M 10-K · filed 2021-09-28 |
| 2019-12-31 | $7.70M 10-K · filed 2020-09-18 |
| 2018-12-31 | $8.40M 10-K · filed 2019-09-09 |
| 2017-12-29 | $22.80M 10-K · filed 2018-09-24 |
| 2016-12-30 | $30.20M 10-K · filed 2017-09-27 |
| 2015-12-31 | $15.90M 10-K · filed 2016-09-13 |
| 2014-12-31 | $22.80M 10-K · filed 2015-11-16 |
| 2013-12-31 | $18.60M 10-K · filed 2014-08-28 |
| 2013-06-30 | $22.44M 10-K · filed 2014-03-10 |
| 2012-12-31 | $0.00 10-Q · filed 2013-01-18 |
| 2012-09-30 | $0.00 10-Q/A · filed 2012-12-20 |
| 2012-06-30 | $0.00 10-K/A · filed 2012-12-20 |
| 2012-03-31 | $0.00 10-Q/A · filed 2012-06-05 |
| 2011-12-31 | $0.00 10-Q · filed 2012-02-07 |
| 2011-09-30 | $2.95M 10-Q · filed 2011-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |